Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Three-gene expression signature predicts survival in early-stage squamous cell carcinoma of the lung.

Skrzypski M, Jassem E, Taron M, Sanchez JJ, Mendez P, Rzyman W, Gulida G, Raz D, Jablons D, Provencio M, Massuti B, Chaib I, Perez-Roca L, Jassem J, Rosell R.

Clin Cancer Res. 2008 Aug 1;14(15):4794-9. doi: 10.1158/1078-0432.CCR-08-0576.

2.

Main histologic types of non-small-cell lung cancer differ in expression of prognosis-related genes.

Skrzypski M, Dziadziuszko R, Jassem E, Szymanowska-Narloch A, Gulida G, Rzepko R, Biernat W, Taron M, Jelitto-Górska M, Marjański T, Rzyman W, Rosell R, Jassem J.

Clin Lung Cancer. 2013 Nov;14(6):666-673.e2. doi: 10.1016/j.cllc.2013.04.010. Epub 2013 Jul 17.

PMID:
23870818
4.

Expression of HIF-1alpha, CA IX, VEGF, and MMP-9 in surgically resected non-small cell lung cancer.

Kim SJ, Rabbani ZN, Dewhirst MW, Vujaskovic Z, Vollmer RT, Schreiber EG, Oosterwijk E, Kelley MJ.

Lung Cancer. 2005 Sep;49(3):325-35.

PMID:
15935515
5.

An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers.

Le QT, Chen E, Salim A, Cao H, Kong CS, Whyte R, Donington J, Cannon W, Wakelee H, Tibshirani R, Mitchell JD, Richardson D, O'Byrne KJ, Koong AC, Giaccia AJ.

Clin Cancer Res. 2006 Mar 1;12(5):1507-14.

6.

Carbonic anhydrase IX in early-stage non-small cell lung cancer.

Kim SJ, Rabbani ZN, Vollmer RT, Schreiber EG, Oosterwijk E, Dewhirst MW, Vujaskovic Z, Kelley MJ.

Clin Cancer Res. 2004 Dec 1;10(23):7925-33. Erratum in: Clin Cancer Res. 2005 Apr 1;11(7):2783.

7.

Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy.

Schrijvers ML, van der Laan BF, de Bock GH, Pattje WJ, Mastik MF, Menkema L, Langendijk JA, Kluin PM, Schuuring E, van der Wal JE.

Int J Radiat Oncol Biol Phys. 2008 Sep 1;72(1):161-9. doi: 10.1016/j.ijrobp.2008.05.025.

PMID:
18722267
8.

Quantitative analysis of carbonic anhydrase IX mRNA in human non-small cell lung cancer.

Simi L, Venturini G, Malentacchi F, Gelmini S, Andreani M, Janni A, Pastorekova S, Supuran CT, Pazzagli M, Orlando C.

Lung Cancer. 2006 Apr;52(1):59-66. Epub 2006 Feb 28.

PMID:
16513206
9.

CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance.

Brennan DJ, Jirstrom K, Kronblad A, Millikan RC, Landberg G, Duffy MJ, Rydén L, Gallagher WM, O'Brien SL.

Clin Cancer Res. 2006 Nov 1;12(21):6421-31.

10.

Prognostic relevance of carbonic anhydrase-IX in high-risk, early-stage cervical cancer: a Gynecologic Oncology Group study.

Liao SY, Darcy KM, Randall LM, Tian C, Monk BJ, Burger RA, Fruehauf JP, Peters WA, Stock RJ, Stanbridge EJ.

Gynecol Oncol. 2010 Mar;116(3):452-8. doi: 10.1016/j.ygyno.2009.10.062. Epub 2009 Nov 13.

11.

Prognostic value of carbonic anhydrase IX and Ki-67 expression in squamous cell carcinoma of the tongue.

Kim SJ, Shin HJ, Jung KY, Baek SK, Shin BK, Choi J, Kim BS, Shin SW, Kim YH, Kim JS, Oosterwijk E.

Jpn J Clin Oncol. 2007 Nov;37(11):812-9.

PMID:
18057013
12.

Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer.

Hussain SA, Ganesan R, Reynolds G, Gross L, Stevens A, Pastorek J, Murray PG, Perunovic B, Anwar MS, Billingham L, James ND, Spooner D, Poole CJ, Rea DW, Palmer DH.

Br J Cancer. 2007 Jan 15;96(1):104-9.

13.

Prognostic value of carbonic anhydrase IX expression in penile squamous cell carcinoma: a pilot study.

Zhu Y, Zhou XY, Yao XD, Zhang SL, Dai B, Zhang HL, Shen YJ, Ye DW.

Urol Oncol. 2013 Jul;31(5):706-11. doi: 10.1016/j.urolonc.2011.04.011. Epub 2011 Jun 12.

PMID:
21664839
14.

Expression of CA-IX is associated with advanced stage tumors and poor survival in oral squamous cell carcinoma patients.

Pérez-Sayáns M, Suárez-Peñaranda JM, Pilar GD, Supuran CT, Pastorekova S, Barros-Angueira F, Gándara-Rey JM, García-García A.

J Oral Pathol Med. 2012 Oct;41(9):667-74. doi: 10.1111/j.1600-0714.2012.01147.x. Epub 2012 Apr 4.

PMID:
22486898
15.

Hemoglobin level predicts outcome for vulvar cancer patients independent of GLUT-1 and CA-IX expression in tumor tissue.

van de Nieuwenhof HP, de Hullu JA, Kaanders JH, Bulten J, Massuger LF, van Kempen LC.

Virchows Arch. 2010 Dec;457(6):693-703. doi: 10.1007/s00428-010-0981-x. Epub 2010 Oct 2.

16.

Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer.

Swinson DE, Jones JL, Richardson D, Wykoff C, Turley H, Pastorek J, Taub N, Harris AL, O'Byrne KJ.

J Clin Oncol. 2003 Feb 1;21(3):473-82.

PMID:
12560438
17.

Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.

Hui EP, Chan AT, Pezzella F, Turley H, To KF, Poon TC, Zee B, Mo F, Teo PM, Huang DP, Gatter KC, Johnson PJ, Harris AL.

Clin Cancer Res. 2002 Aug;8(8):2595-604.

18.

Expression of carbonic anhydrase IX in astrocytic tumors predicts poor prognosis.

Haapasalo JA, Nordfors KM, Hilvo M, Rantala IJ, Soini Y, Parkkila AK, Pastoreková S, Pastorek J, Parkkila SM, Haapasalo HK.

Clin Cancer Res. 2006 Jan 15;12(2):473-7.

19.
20.

EMX2 Is a Predictive Marker for Adjuvant Chemotherapy in Lung Squamous Cell Carcinomas.

Yue D, Li H, Che J, Zhang Y, Tolani B, Mo M, Zhang H, Zheng Q, Yang Y, Cheng R, Jin JQ, Luh TW, Yang C, Tseng HH, Giroux-Leprieur E, Woodard GA, Hao X, Wang C, Jablons DM, He B.

PLoS One. 2015 Jul 1;10(7):e0132134. doi: 10.1371/journal.pone.0132134. eCollection 2015.

Supplemental Content

Support Center